In one study, their dataset contains NORMAL tissue while my dataset contains CANCER tissue of the same organ. Using canonical markers they have annotated the cell types(epithelial, b cell, t cell etc.). But for annotating cell states/cell subtypes they have mentioned for- CD4+ T cells included naive T cells (SELL), T helper (TH) and TH-like (IL7R, CCR6,CCL20), T effector memory (TEM) (LMNA) and Tregulatory (Treg) (FOXP3,CTLA4) cells.But in methods they have mentioned that they used deferentially expressed genes and pathway enrichment analysis to annotate the cell sates. so can i annotate the cell states in my dataset using the cell state genes they have mention for their dataset, especially for epithelial cells as these are highly altered in cancer tissue(my dataset) in comparison to normal tissue(their dataset)?